# Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

> **NCT02153333** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **PROCEDURE:** Serum sample

## Key facts

- **NCT ID:** NCT02153333
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2015-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153333, "Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02153333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*